Armistice Capital, LLC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:51 pm Sale |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
Armistice Capital, LLC | 500,000 0.710% |
-2,988,000 (-85.67%) |
Filing |
| 2023-02-14 1:10 pm Purchase |
2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
Armistice Capital, LLC | 3,488,000 6.060% |
3,488,000 (New Position) |
Filing |